PERCEPTIVE ADVISORS LLC

Average Profitability
20.04%
Insider Buys Quantity
115
Insider Buys Sum
$816.82M
Insider Sells Quantity
22
Insider Sells Sum
$33.75M

Insider Activity of PERCEPTIVE ADVISORS LLC

According to the SEC Form 4 filings, PERCEPTIVE ADVISORS LLC, being in a position of

  1. 10 percent owner at Acrivon Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 2353000 shares for $20M, and sold 0 shares,
    over all time since 2024-04-11, has bought 2353000 shares for $20M, and sold 0 shares.

The largest purchase of all time was on 2021-06-09 and amounted to 5500000 shares of Nautilus Biotechnology, Inc. for $55M.

The largest sale of all time was on 2016-08-25 and amounted to 2200000 shares of Amicus Therapeutics, Inc. for $14.98M.

Biography of PERCEPTIVE ADVISORS LLC

No biography is available at this moment.

2024-08-12PurchaseMeiraGTx Holdings plc
MGTX
1.25M
1.9341%
$4.00$5M+33.25%
2024-04-11PurchaseAcrivon Therapeutics, Inc. Common Stock
ACRV
10 percent owner
2.35M
8.4743%
$8.50$20M-17.22%
2024-04-05PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
37,712
0.0643%
$4.74$178,755+0.42%
2024-04-04PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
140,281
0.2374%
$4.67$655,112+1.07%
2024-04-03PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
309,847
0.5185%
$4.09$1.27M+13.73%
2024-04-02PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
186,051
0.3061%
$3.44$640,015+32.39%
2024-04-01PurchaseAldeyra Therapeutics, Inc.
ALDX
10 percent owner
8,374
0.0141%
$3.25$27,216+43.12%
2024-02-01PurchaseAstria Therapeutics, Inc.
ATXS
director
2.48M
5.6893%
$12.09$30M-17.48%
2024-01-11PurchaseSolid Biosciences Inc.
SLDB
3.41M
12.2033%
$5.53$18.86M+2.29%
2023-12-29PurchaseAthira Pharma, Inc.
ATHA
163,954
0.4272%
$2.38$390,211+5%
2023-12-29PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
115,774
0.2752%
$7.24$838,204-25.05%
2023-12-28PurchaseAthira Pharma, Inc.
ATHA
409,598
1.0852%
$2.44$999,419+2.86%
2023-12-28PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
126,116
0.2934%
$7.08$892,901-25.68%
2023-12-27PurchaseAthira Pharma, Inc.
ATHA
32,134
0.0833%
$2.28$73,266+9.57%
2023-12-27PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
79,726
0.1901%
$7.20$574,027-24.2%
2023-12-26PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
54,652
0.1301%
$6.49$354,691-15.77%
2023-12-22PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
250,000
0.5943%
$6.67$1.67M-18.52%
2023-12-21PurchaseAstria Therapeutics, Inc.
ATXS
director
740,000
2.0257%
$6.20$4.59M+76.96%
2023-12-21PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
200,000
0.4555%
$6.17$1.23M-14.73%
2023-12-19PurchaseVerrica Pharmaceuticals Inc.
VRCA
10 percent owner
277,008
0.6854%
$5.36$1.48M+6.78%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.